Cases & Deals

NewBridge Pharmaceuticals raises capital in Series C round

Client(s) NewBridge Pharmaceuticals Limited

Jones Day represented NewBridge Pharmaceuticals Limited, a specialty therapeutics company focused on pharmaceutical and biologics, in connection with its issuance of $48 million of Series C Convertible Preferred Stock in a private placement to Elan Corporation, Burrill & Company, and Kuwait Life Sciences Company.